Lethal acute respiratory distress syndrome during anti-TNF-α therapy for rheumatoid arthritis

Clinical Rheumatology

Volumn 25, Issue 3, 2006, Pages 430-432

  Zimmer, Christian ^a   Beiderlinden, Martin ^a   Peters, Jürgen ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

ARDS; Community acquired pneumonia; Etanercept

Indexed keywords

AMPHOTERICIN B; CEFOTIAM; CEFTRIAXONE; CIPROFLOXACIN; CLARITHROMYCIN; CORTICOSTEROID; ERYTHROMYCIN; ETANERCEPT; FLUCONAZOLE; GENTAMICIN; HYPERTENSIVE FACTOR; ILOPROST; IMIPENEM; METHOTREXAT LEDERLE; METHOTREXATE; NITRIC OXIDE; NORADRENALIN; OXYGEN; PENICILLIN G; PREDNYLIDENE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; ARTICLE; CASE REPORT; DISEASE COURSE; DRUG MEGADOSE; FEMALE; HUMAN; IMMUNE DEFICIENCY; INFECTION; LOBAR PNEUMONIA; LUNG INFECTION; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SEPSIS; SEPTIC SHOCK; TREATMENT DURATION;

ARTHRITIS, RHEUMATOID; COMMUNITY-ACQUIRED INFECTIONS; DRUG THERAPY, COMBINATION; FATAL OUTCOME; FEMALE; GLUCOCORTICOIDS; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENTS; METHOTREXATE; MIDDLE AGED; PNEUMONIA, PNEUMOCOCCAL; PREDNISOLONE; RECEPTORS, TUMOR NECROSIS FACTOR; RESPIRATORY DISTRESS SYNDROME, ADULT; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33645793077     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-005-0008-1     Document Type: Article

References (15)

1. Cairns AP, Taggart AJ (2002) Anti-tumour necrosis factor therapy for severe inflammatory arthritis: Two years of experience in Northern Ireland. Ulster Med J 71:101-105
2. Klareskog L, Moreland LM, Bohen SB et al (2001) Global safety and efficacy of up to five years of etanercept (Enbrel) therapy. Arthritis Rheum 44:S77 (abstract no. 150)
3. Kroesen S, Widmer AF, Tyndall A, Hasler P (2003) Serious bacterial infections in patients with rheumatoid arthritis under anti-TNF alpha therapy. Rheumotology 42:617-621
4. Hydrich KL, Silmann AJ, Watson KD, Symmons DPM (2004) Anti-tumour necrosis factor α therapy in rheumatoid arthritis: An update on safety. Ann Rheum Dis 63:1538-1543
5. Doran MF, Crowson CS, Pond GR, O'Fallon WM, Gabriel SE (2002) Frequency of infection in patients with rheumatoid arthritis compared with controls - a population based study. Arthritis Rheum 46:2287-2293
6. Le Gall JR, Lemeshow S, Saulnier F (1993) A new simplified acute physiology score (SAPS II) based on a European/North American multicenter study. JAMA 270:2957-2963
7. Ritz MA, Jost R (2001) Severe pneumococcal pneumonia following treatment with Infliximab for Crohn's disease. Inflamm Bowel Dis 7:327
8. Baghai M, Osmon DR, Wolk DM, Wold LE, Haidukewych GJ, Matteson EL (2001) Fatal sepsis with rheumatoid arthritis treated with etanercept. Mayo Clin Proc 76:653-656
9. Sabath DF, Holman J, Wallis WJ (2002) Serious infection reports with etanercept (Enbrel) therapy. Ann Rheum Dis 61(Suppl 1):38 (abstract no. 0P0099)
10. Weinblatt ME, Kremer JM, Bankhurst AD et al (1999) A trial of etanercept, a recombinant tumor necrosis factor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate. N Engl J Med 340:253-259
11. Lipsky PE, Van Der Heijde D, St Clair EW et al (2000) Infliximab and methotrexate in the treatment of rheumatoid arthritis. N Engl J Med 343:1594-1602
12. Van Der Poll T, Keogh CV, Buurman WA, Lowry SF (1997) Passive immunization against tumor necrosis factor-alpha impairs host defence during pneumococcal pneumonia in mice. Am J Respir Crit Care Med 155:603-608
13. Culy CR, Keating GM (2002) Etanercept. An update review of its use in rheumatoid arthritis, psoriatic arthritis and juvenile rheumatoid arthritis. Drugs 62:2493-2537
14. Osterheert JJ, Bonten MJM, Hak E et al (2003) Severe community-acquired pneumonia: What's in a name? Curr Opin Infect Dis 16:153-159
15. Wright SA, Taggart AJ (2004) Pneumococcal vaccination for RA patients on TNF-α antagonists. Rheumatology 43:523